Image provided by: Texas A&M University
About The Battalion. (College Station, Tex.) 1893-current | View Entire Issue (March 27, 2002)
6A Wednesday, March 27, 2002 I Heading for a Wedding? AGGIELlf[ THE BATTAtloi Compass College Ministries would like to invite all engaged couples and those just thinking about getting engaged to join us for a 6-week seminar on how to build a lasting marriage. civ civ ctko civ civ civ . Me . Aj cKs Tuesday evenings beginning April 2nd Rudder Tower Room 301, 8:30 pm Sign up by March 29th $75 per couple For registration information please call 779-2434 Registration Includes: Seminar Notebook • PREPARE Evaluation & Reading • Marriage Enrichment Material ^ CYBERTERRORISM: IS IT A REAL THREAT TO THE AMERICAH PREAMP WHEN: Wednesday, March 27, 2002 Noon to 1 pm (Pizza will be available) WHERE: MSC Room 226 Can the United States be crippled by an on-line attack? What research is going on to promote and advance the technology surrounding the need to combat cyberterrorism? Which prevention strategies will work, which technologies are efficient, and which forecasting methods are the most accurate? Come find the answers to these questions and more. Ihe ionibshell IManual Style I.AMKN Stovi h WhSnJ WAS Th£ LAST TI/VnS APAP2T/V\eiOT /vnanJAShgs LiSTesjeo... HXSHPT WhEkJ IT was Tl/Vv£ TO PAV teHiOT? Here at University Commons Apartments, our first concern is pleasing you, after all we live here tool S4bed/2bath $335 mo. y2bed/l V4 bath $395 mo. y 2bed/2bath $400 mo. ||||||]l %/Totally furnished |J f"! | \f © f* S I T Y ^Individual leases yAnd so much more! COMMONS a f» a n t m e » t s We fiave everythdng' all the other great apartment complexes have, except the high prices—that ’ s why i we’re thc bcst neat unoeR thg sun! 950 Colgate Drive - Phone (979)764-8999 - Fax(979)764-1077 The Bombshell Manual of Style Laren Stover Illustrations by Ruben Toledo Hyperion Books In the ultimate handguide to becoming a bombshell, author Laren Stover dishes the scoop on every aspect of a bombshell’s life, and Ruben Toledo provides sharp illustra tions of a bombshell’s stilettos, panties and perfumes. “She behaves as if all life’s a movie in which she is the star, Stover writes. Stover, editor-at-large of Contents magazine, describes the tantrums of a bombshell and claims brunettes are prone to break ing anything from glasses to windows. “[A brunette] also has a sense of rhythm and will smash in sync to whatever music is on, preferably something jazzy, although Tchaikovsky and Strauss also work.” Stover said a bombshell plays dress up everyday and refers constantly to days-of-old bombshells such as Marilyn Monroe, Jayne Mansfield, Dorothy Dandridge and Ava Gardner. Stover describes a bombshell’s favorite perfumes, scarves, favorite authors and books like Jack Kerovac, Thomas Wolfe’s "You Can’t Go Home Again” and D.H. Lawrence’s “Women in Love.” Stover said a bombshell’s favorite music varies from Maria Callas, Tito Puente and Brigitte Bardot and Eartha Kitt. There is also a list of hotels for bombshells in New York and Los Angeles. One of the biggest bombshell tips is that weather is never deciding factor in what she will wear. Stover convinces readers that all girls were born with a bombshell within and gives readers a wonderful pint-sizecj book that bombshells everywhere can find handy. As Maris^ Tomei suggests, it is “the perfect little book for anyone who* wants to fulfill her own bombshell aspirations." (Grade:^V TATE HE BAIT Boi SAN ANT )inewhere ii age, and it v The 2-yeai id of the fi iethodically, to the nexi fithout detec Richard O: trace her ste PEOPLE IN THE NEWS lomes o Ihouston {I :es of Enron Houston As coming do\ lek before tl Irow out the season. The same italled 10-f elling out ‘‘E e ballpark’s i turned to hau ree decade inned. 'Whenever w ! install it to ars,” said Jo manager irp. "I never |ing to see En m Feb. 27 th jyout Enron’s [n naming rig Enron mpany suite kets for 35 be ihe buyout all irt negotiatinj nies interestei Jits. Astros iane hoped d-April. lompanies th, erest in nam «o Inc., C irp. and Lane based in Hou tudy she sist hea aspirin )ALLAS (AP) - sts that some tin to ward sy not be getti 6ythought the; ihe study in i journal Circt many as 75 p ! wed some r Hare Krishnas plan garden to honor George Harrison • , . r Puicufl ^"thinning ef Mayapur is about 60 miles north ot '- aP li (;nl ,. i „ u CALCUTTA, India (AP) — Hare Krishnas are planning a garden in eastern India in the memory of former Beatle George Harrison, a longtime devotee of Hinduism who died last year. “We are going to set up the George Harrison Garden at Mayapur to commemorate his contri bution in spreading the messages of Lord Krishna through his music,” Dayaram Das, head of the Calcutta chapter of the International Society of Krishna Consciousness, said Monday. Harrison, known as the “quiet Beatle, long, intensely intimate relationship wit* 1 mysticism, music and Hinduism. The HareKn^ follower was beloved by Indians who a] his respect for their culture and religion. In one of Harrison’s most popular so “My Sweet Lord,” he chants “Hare Kris ni' he pays tribute to Hinduism’s most revere | Harrison died of cancer on Nov. 29 at age fepirin works t of thro *niical in the Yelets sticky clotting. F iu sed by clots, ^be study fo did not 'wmboxane ir them 3 to die of a los e in whom a Contraceptive Injection medroxyprogesterone acetate injectable suspension Esir-tK corvtrol ^ou -tKir-xk ae»ou-t jus-t •T-xa^ear DEPO-PROVERA"’ Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP) This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. What is DEPO-PROVERA Contraceptive Injection? DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an Intramuscular injection (a shot) in the buttock or upper arm once every 3 months (I 3 weeks). To continue your contraceptive protection, you must return for your next injection promptly at the end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your egg cells from ripening. If an egg is not released from the ovaries during your menstruafcycle, it cannot become fertiTized by sperm and result in pregnancy. DEPO-PROVERA also causes changes in the lining of your uterus that make it less likely for pregnancy to occur How effective is DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the recommended dosage schedule exactly (see “How often do I get my shot of DEPO-PROVERA Contraceptive Injection?”). To make sure you are not pregnant when you first get DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during the first 5 days of a normal menstrual period; ONLY within the first 5 days after childbirth if not breast-feeding; and, if exclusively breast-feeding, ONLY at the sixth week after childbirth. It is a long-term injectable contraceptive when administered at 3-month (13-week) intervals. DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable methods of birth control available. This means that the average annual pregnancy rate is less than one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive ■methods depends in part on how reliably each woman uses the method. The effectiveness of DEPO-PROVERA depends only on the patient returning every 3 months,(I 3 weeks) for her next injection Your heafth-cane provider will help you compare DEPO-PROVERA with other opntraceptive methods and give you the information you need in order to decide which contraceptive method is the right choice for you. The following table shows the percent of women who got pregnant while using different kinds of ' contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected , in women who use each method exactly as it should be used) and the typical rate of pregnancy (which includes women who became pregnant because they forgot to use their birth control or because they did not follow the directions exactly). Percent of Women Experiencing an Accidental Pregnancy in the First Year of Continuous Use Method Lowest Expected Typical DEPO-PROVERA 0.3 0.3 Implants (Norplant) 0.2* 0.2* Female sterilization 0.2 0.4 Male sterilization 0.1 0.15 Oral contraceptive (pill) 3 Combined 0.1 Progestogen only 0.5 joe 3 Progestasert 2.0 Copper T 380A 0.8 Condom (without spermidde) 2 12 Diaphragn (with spermidde) 6 18 Cervical cap 6 18 Withdrawal 4 18 Periodic abstinence 1-9 20 Spermicide alone 3 21 Vaginal Sponge used before childbirth 6 18 used after childbirth 9 28 No method - 85 85 Source. Tfussell et ai. Obstet Gynecol 1990.76:558-567. ' "From Norplant 4 ’ package insert. Who should not use DEPO-PROVERA Contraceptive injection? Not all women should use DEPO-PROVERA. You should not use DEPO-PROVERA if you have any of the' following conditions: • if you think you might be pregnant • if you have any vaginal bleeding without a known reason • if you have had cancer of the breast • if you have had a stroke • if you have or have had blood clots (phlebitis) in your legs • if you have problems with your liver or liver disease • if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other ingredients). What other things should I consider before using DEPO-PROVERA Contraceptive Injection? You will have a physical examination before, your doctor prescribes DEPO-PROVERA. It is important to tell your health-care provider if you have any of the following; • a family history of breast cancer • an abnormal mammogram (breast x-ray),-fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples • kidney disease • irregular or scanty menstrual periods • high blood pressure • migraine headaches • asthma • epilepsy (convulsions or seizures) • diabetes or a family history of diabetes • a history of depression • if you are taking any prescription or over-the-counter medications This product is intended to prevent pregnancy. It does not protect against transmission of HIV (AIDS) and other sexually transmitted diseases such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. What if I want to become pregnant after using DEPO-PROVERA Contraceptive Injection? Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last injection for its effect to wear off. Based on the results from a large study done in the United States, for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that about half of those who become pregnant will do so in about 10 months after their last injection; about two thirds of those who become pregnant will do so in about 12 months; about 83% of those who become pregnant will do so in about 15 months; and about 93% of those who become pregnant will do so in about 18 months after their last injection. The length of time you use DEPO-PROVERA has no effect on how longit takesyou to become pregnant after >ou stop using it. What are the risks of using DEPO-PROVERA Contraceptive Injection? I .Irregular Menstrual Bleeding The side effect reported most frequently by women who use DEPO-PROVERA for contraception is a change in their normal menstrual cycle. During the first year of using DEPO-PROVERA, you might have one or mote of the following changes: irregular or unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no oleeding at all. Unusually heavy or continuous bleeding, however; is not a usual effect of DEPO-PROVERA; and if this happens, you should see your hearth-care provider right away. With continued use of DEPO-PROVERA, bleeding usually decreases, and many women stop having periods completely. In clinical studies of DEPO-PROVERA, 55% of the women studied reported no menstrual bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA causes a resting state in your ovaries When your ovaries do not release an egg monthly, the regular monthly growth of the lining of your uterus does not occur and, therefore, the bleeding that comes with your normal menstruation does not take place. When you stop using DEPO-PROVERA your menstrual period will usually, in time, return to its normal cycle. 2. Bone Mineral Changes Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in your bones. This could increase your risk of developing bone fractures. The rate of bone mineral loss is greatest in the early years of DEPO-PROVERA use, but after that, it begins to resemble the normal rate of age-related bone mineral loss. 3. Cancer Studies of women who have used different forms of contraception found that women who used DEPO-PROVERA for contraception had no increased overall risk of developing cancer of the breast, ovary, uterus, cervix, or liver However women under 35 years of age whose first exposure to DEPO-PROVERA was within the previous 4 to 5 years may have a slightly increased risk of developing breast cancer similar to that seen with oral contraceptives. You should discuss this with your health-care provider 4 Unexpected Pregnancy Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental pregnancy for women who get their shots regularly (every 3 months [I 3 weeks]) is very low. While there have been reports of an increased risk of low birth weight and neonatal infant death or other health problems in infants conceived close to the time of injection, such pregnancies are uncommon. If you think you may have become pregnant while using DEPO-PROVERA for contraception, see your health-cane provider as soon as possible. 5 Allergic Reactions Some women using DEPO-PROVERA Contraceptive Injection have reported severe and potentially life-threatening allergic reactions known as anaphylaxis and anaphvlactoid reactions. Symptoms include the sudden onset of hives or swelling and itching of the skin, breathing difficulties, and a drop in blood pressure. S.Other Risks Women who use hormone-based contraceptives may have an increased risk of blood clots or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should tell your health-care provider if you have any of the problems listed In the next section What symptoms may signal problems while using DEPO-PROVERA Contraceptive Injection? Call your health-care provider immediately if any of these problems occur following an injection of DEPO-PROVERA; • sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible dot In the lung) 6 ^ • sudden severe- headache or vomiting, dizziness or fainting, problems with your eyesight or speech, weakness, or numbness in an am or leg (indicating a possible stroke) • severe pain or swelling in the calf (indicating a possible clot in the leg) • unusually heavy vaginal bleeding • severe pain or tenderness In the'lower abdominal area • persistent pain, pus, or bleeding at the injection site What are the possible side effects of DEPO-PROVERA Contraceptive Iniection? I . Weight Coin ‘ You may experience a weight gam while you are using DEPO-PROVERA. About two thirds of the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds Hi irino firc+ \/<aor rsf i rc^s VXi i rsoow 4-,-. -.-.I-. '.—ui. . .. .c- . , ' . ! years, or approximately average total of 13,8 pounds ov - I years gained an . - J ; over those 4 years, or approximately 3.5 pounds per year Women who continued for 6 years gained an average total of 16.5 pounds over those 6 years or anproximatey 2.75 pounds per year ' rtf ' 2.0ther Side Effects In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years some tl ? e f °"p win 8 efferts that may or may not have been related to their use of DEPO-PROVERA Ir tegular menstrual bleeding, amenorrhea, headache, nervousness abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal discharge or irritation, breast swelling and tenderness, bloating, swelfing of the hands or feet e ^ n * SS,< ^ n ‘ *2®' P e,v ' c P a ' n . bo hair growth or excessive hair loss. rash, hot a KTk ? ther were ?P orted b Y ver y few of the women in the clinical tnafe.but some of these could be serious. These include convulsions, jaundice urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lark of return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer, or cervical cancer If these or any other problems occur dunng your use of DEPO-PROVERA, discuss them with your health-care provider Contraceptive Injection?" 3 ^ ,0 "° Wed dUrinS USC 0t D^°-PROVERA 1. Missed Periods ?, U ^ the tkTI J yOU are u ,^ DEPO-PROVERA for contraception, you may skip a period, or your pen<xJs may stop completely. If you have been receiving your DEPO-PROVERA injections regularly every 3 months (I 3 weeks), then you are probably not pregnant. However, if you think that you may be pregnant, see your health-care provider. ' 2. Laboratory Test Interactions Dlpo a pROV^A le for f< ?-^S^co^? rat0r T' t t? ? * ^ y°, ur health-care provider that you are using DEPO-PROVERA f corrtrace P tlon Certain Wood tests are affected by hormones such as 3 Drug Interactions . Cytadren (ammoglutethimide) is an anticancer drug that may significantly decrease the elfecWenessof^tPO-PROvE'RA if the two drugs are fven during the^mlT^e A ~th9 u ^ DEPO-PROVERA can be passed to the nursing infant in the breast milk no harmful effects have been found in these children. DEPO-PROVERA does not prevent the breasts from SEPOpIovFRrthaTis"^ 6 'iT* d mothers. However to minimize the airrount of 6 to lnfant ln the first weeks after birth, you should wait until 6weeks after chikdbirth before you start using DEPO-PROVERA for contraeptkan How often do I get my shot of DEPO-PROVERA Contraceptive injection? The recommended dose of DEPO-PROVERA is 150 mg every 3 months (13 weeks) given in a single intramuscular iniection in the buttock or upper arm. To make sure that you are noNaregnant at !he hme of the first injection, it is essential that the injection be given O^ILY during P the first DEP<0 PROVERA MuIstIs ' PenOCl the delivery of a child, the first infection of r r i^i 179, S T be glven '' ,/,thin 5 da 7 s after childbirth if you are not breast-feeding or fl T week-? hen h ' db ' rth ! yOU are l exduslv « | y breast-feeding If you wait longer than 3 months ♦' n)eCt ' ons '2. r k>nger th i?1 6 weeks after delivery, your health-care provider ould determine that you are not pregnant before giving you your injection of DEPO-PROVERA ^ only ' ■ CB-7-S Pharmacia & Upjohn Co Kalamazoo, Ml 49001 Domjoany Pharmacia & Upjohn >ign up fc intends 1 mstin <ap) - ,ailt to be ann ster s have t Wnesday for a ^blocks comp “tomers at hor M °rethan 50, ysh ed to add th dover the pas' ’8the total to 31 1 Sa 'd Public U Mesperson Te We were told tates ’ experien< ir 8 e response I ^ “We’re nc ^ need to sig ^ that this liable — if ^ ^ need to sign ! i